Alector downgraded to Underperform at BofA after Alzheimer’s trial miss
As previously reported, BofA downgraded Alector (ALEC) to Underperform from Neutral with a price target of $1, down from $9, after ALOO2 missed ...
Alector downgraded to Underperform from Neutral at BofA
BofA downgraded Alector (ALEC) to Underperform from Neutral with a price target of $1, down from $9.Don't Miss our Black Friday Offers:Unlock ...
TipRanks on MSN9h
Vigil Neuroscience initiated with an Outperform at William Blair
William Blair initiated coverage of Vigil Neuroscience (VIGL) with an Outperform rating and $18.67 fair value estimate. Vigil ...